{"transactions":[{"id":2454530,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2022-01-03T06:13:52.000Z","date":"2021-12-22","kind":"purchase","acquired":true,"shares":109329,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":109329,"derivative":{"exercise_price":3.5,"exercise_date":"2021-12-27","expiration_date":"2026-12-28","underlying":"Common Stock","underlying_shares":109329},"source":{"system":"sec-edgar","filing":"0001104659-22-000036","document":"tm2136682-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465922000036/tm2136682-1_4seq1.xml","form_type":"4"}},{"id":2454529,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-01-03T06:13:52.000Z","date":"2021-12-22","kind":"purchase","acquired":true,"shares":145773,"price":3.43,"value":500001.39,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":5703544,"source":{"system":"sec-edgar","filing":"0001104659-22-000036","document":"tm2136682-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465922000036/tm2136682-1_4seq1.xml","form_type":"4"}},{"id":2492266,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2021-11-30T14:49:21.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":375000,"derivative":{"exercise_price":3.5,"exercise_date":"2021-12-02","expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001104659-21-144901","document":"tm2134252-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465921144901/tm2134252-1_4.xml","form_type":"4"}},{"id":2492265,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-11-30T14:49:21.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":500000,"price":3,"value":1500000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":5557771,"source":{"system":"sec-edgar","filing":"0001104659-21-144901","document":"tm2134252-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465921144901/tm2134252-1_4.xml","form_type":"4"}},{"id":2537432,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2021-10-21T08:47:14.000Z","date":"2021-10-18","kind":"purchase","acquired":true,"shares":1661807,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":1661807,"derivative":{"exercise_price":1.715,"exercise_date":"2021-10-18","expiration_date":"2026-10-18","underlying":"Common Stock","underlying_shares":1661807},"source":{"system":"sec-edgar","filing":"0001567619-21-018515","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000156761921018515/doc1.xml","form_type":"4"}},{"id":2537431,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-10-21T08:47:14.000Z","date":"2021-10-18","kind":"purchase","acquired":true,"shares":1661807,"price":1.715,"value":2849999.005,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC (\"MT\") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":5057771,"source":{"system":"sec-edgar","filing":"0001567619-21-018515","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000156761921018515/doc1.xml","form_type":"4"}},{"id":2931593,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":2,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":3,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":4,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":5,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134385,"kind":"organization","name":"Metuchen Therapeutics, LLC","position":6,"cik":"0001836798","reported_name":"Metuchen Therapeutics, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-28T19:46:47.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":3395964,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to add Reporting Persons and to adjust the number of securities acquired to account for the same."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"See Note (2) in Exhibit 99.1."}],"balance_after":3395964,"source":{"system":"sec-edgar","filing":"0001567619-20-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000156761920021618/doc1.xml","form_type":"4/A","original_submission_date":"2020-12-03"}}]}